Stancill Lab - Deletion of Thioredoxin Reductase Disrupts Redox

Journal article

Jennifer S. Stancill, Polly A. Hansen, A. Mathison, E. Schmidt, J. Corbett
Function, 2022

Semantic Scholar DOI PubMedCentral PubMed

Cite

APA Click to copy
Stancill, J. S., Hansen, P. A., Mathison, A., Schmidt, E., & Corbett, J. (2022). Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function. Function.

Chicago/Turabian Click to copy
Stancill, Jennifer S., Polly A. Hansen, A. Mathison, E. Schmidt, and J. Corbett. “Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function.” Function (2022).

MLA Click to copy
Stancill, Jennifer S., et al. “Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function.” Function, 2022.

BibTeX Click to copy

@article{jennifer2022a,
  title = {Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function},
  year = {2022},
  journal = {Function},
  author = {Stancill, Jennifer S. and Hansen, Polly A. and Mathison, A. and Schmidt, E. and Corbett, J.}
}

Abstract

Abstract Reactive oxygen species (ROS) have been implicated as mediators of pancreatic β-cell damage. While β-cells are thought to be vulnerable to oxidative damage, we have shown, using inhibitors and acute depletion, that thioredoxin reductase, thioredoxin, and peroxiredoxins are the primary mediators of antioxidant defense in β-cells. However, the role of this antioxidant cycle in maintaining redox homeostasis and β-cell survival in vivo remains unclear. Here, we generated mice with a β-cell specific knockout of thioredoxin reductase 1 (Txnrd1fl/fl; Ins1Cre/+, βKO). Despite blunted glucose-stimulated insulin secretion, knockout mice maintain normal whole-body glucose homeostasis. Unlike pancreatic islets with acute Txnrd1 inhibition, βKO islets do not demonstrate increased sensitivity to ROS. RNA-sequencing analysis revealed that Txnrd1-deficient β-cells have increased expression of nuclear factor erythroid 2-related factor 2 (Nrf2)-regulated genes, and altered expression of genes involved in heme and glutathione metabolism, suggesting an adaptive response. Txnrd1-deficient β-cells also have decreased expression of factors controlling β-cell function and identity which may explain the mild functional impairment. Together, these results suggest that Txnrd1-knockout β-cells compensate for loss of this essential antioxidant pathway by increasing expression of Nrf2-regulated antioxidant genes, allowing for protection from excess ROS at the expense of normal β-cell function and identity.